Evidence map›Paper›PMID 40821708›Full record

ArticleToxicology reports2025

Rit B Gurung, Laurie C Dolan, Benjamin G Arceneaux, Hiroe Go, Eun Jung Park

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Rit B GurungGeneChem Inc., A-201, 187 Techno 2-ro, Yuseong-gu, Daejeon 34025, Republic of Korea.
Laurie C DolanGRAS Associates, LLC, 11810 Grand Park Avenue, Suite 500, North Bethesda, MD 20852, United States.
Benjamin G ArceneauxGRAS Associates, LLC, 11810 Grand Park Avenue, Suite 500, North Bethesda, MD 20852, United States.
Hiroe GoGeneChem Inc., A-201, 187 Techno 2-ro, Yuseong-gu, Daejeon 34025, Republic of Korea.
Eun Jung ParkGeneChem Inc., A-201, 187 Techno 2-ro, Yuseong-gu, Daejeon 34025, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

6'-Sialyllactose (6'-SL) sodium salt is the sodium salt of a naturally occurring trisaccharide found in dairy products and human milk. 6'-SL sodium salt formulations produced by different methods have been the subject of other safety studies and are approved for use in food in the United States and other countries. Because the manufacturing process can influence the toxicological profile of a substance, studies were undertaken to assess the safety of 6'-SL sodium salt produced by a novel manufacturing process. The results of genetic toxicity tests (bacterial reverse mutation assay, an

Indexed as

6′-Sialyllactose sodium salt6′-SLChronic toxicityGenetic toxicityNo-observed-adverse-effect level (NOAEL)Rats

Identifiers

PMID40821708
PMCPMC12355482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.